NRX Pharmaceuticals Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | +0.0% | +100.0% | +25.0% | +0.0% | +10,000.0% | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | +303,849.2% | +90.7% | -15.9% | -21.5% | -53.6% | -39.1% | |
| – | +648.4% | -99.7% | +413,199.6% | +555.3% | -63.5% | -48.1% | -5.0% | -3.3% | |
| – | – | -29.1% | +2,993.0% | +331.6% | -53.4% | -37.8% | -28.6% | -14.0% | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -67.9% | +25,350.0% | -97.4% | +799.2% | -37.8% | |
| – | – | +497.8% | -10,610.3% | – | – | – | – | – | |
| – | – | +416.3% | -46,925.6% | – | – | – | – | – | |
| – | – | +517.9% | -12,777.2% | – | – | – | – | – | |
| – | – | +497.8% | -10,598.5% | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.